113 related articles for article (PubMed ID: 15046606)
1. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases.
Schmid AC; Woscholski R
Biochem Soc Trans; 2004 Apr; 32(Pt 2):348-9. PubMed ID: 15046606
[TBL] [Abstract][Full Text] [Related]
2. The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway.
Seo JH; Ahn Y; Lee SR; Yeol Yeo C; Chung Hur K
Mol Biol Cell; 2005 Jan; 16(1):348-57. PubMed ID: 15537704
[TBL] [Abstract][Full Text] [Related]
3. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.
Cantley LC; Neel BG
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4240-5. PubMed ID: 10200246
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the PTEN phosphatase.
Gericke A; Munson M; Ross AH
Gene; 2006 Jun; 374():1-9. PubMed ID: 16675164
[TBL] [Abstract][Full Text] [Related]
5. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
Freeley M; Park J; Yang KJ; Wange RL; Volkov Y; Kelleher D; Long A
Cell Signal; 2007 Dec; 19(12):2444-57. PubMed ID: 17826953
[TBL] [Abstract][Full Text] [Related]
6. Targeting PTEN using small molecule inhibitors.
Mak LH; Woscholski R
Methods; 2015 May; 77-78():63-8. PubMed ID: 25747336
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes.
Harris SJ; Parry RV; Westwick J; Ward SG
J Biol Chem; 2008 Feb; 283(5):2465-9. PubMed ID: 18073217
[TBL] [Abstract][Full Text] [Related]
8. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.
Vo TT; Fruman DA
Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921
[TBL] [Abstract][Full Text] [Related]
9. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
[TBL] [Abstract][Full Text] [Related]
10. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation.
Wang J; Ouyang W; Li J; Wei L; Ma Q; Zhang Z; Tong Q; He J; Huang C
Cancer Res; 2005 Aug; 65(15):6601-11. PubMed ID: 16061640
[TBL] [Abstract][Full Text] [Related]
11. Biochemistry and structure of phosphoinositide phosphatases.
Kim YJ; Jahan N; Bahk YY
BMB Rep; 2013 Jan; 46(1):1-8. PubMed ID: 23351377
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide3-kinase regulates actin polymerization during delayed phagocytosis of Helicobacter pylori.
Allen LA; Allgood JA; Han X; Wittine LM
J Leukoc Biol; 2005 Jul; 78(1):220-30. PubMed ID: 15809290
[TBL] [Abstract][Full Text] [Related]
13. Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases.
Mistafa O; Ghalali A; Kadekar S; Högberg J; Stenius U
J Biol Chem; 2010 Sep; 285(36):27900-10. PubMed ID: 20605778
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 5-phosphatases: How do they affect tumourigenesis?
Miyazawa K
J Biochem; 2013 Jan; 153(1):1-3. PubMed ID: 23015060
[TBL] [Abstract][Full Text] [Related]
15. Ribosomal targeting strategy and nuclear labeling to analyze photoreceptor phosphoinositide signatures.
Rajala A; Rajala R; Teel K; Rajala RVS
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Aug; 1867(8):159161. PubMed ID: 35427794
[TBL] [Abstract][Full Text] [Related]
16. Opportunities and challenges for the development of covalent chemical immunomodulators.
Backus KM; Cao J; Maddox SM
Bioorg Med Chem; 2019 Aug; 27(15):3421-3439. PubMed ID: 31204229
[TBL] [Abstract][Full Text] [Related]
17. Distinct inactivation of PI3K signalling by PTEN and 5-phosphatases.
Leslie NR; Dixon MJ; Schenning M; Gray A; Batty IH
Adv Biol Regul; 2012 Jan; 52(1):205-13. PubMed ID: 21930147
[No Abstract] [Full Text] [Related]
18. PTEN inhibitors: an evaluation of current compounds.
Spinelli L; Lindsay YE; Leslie NR
Adv Biol Regul; 2015 Jan; 57():102-11. PubMed ID: 25446882
[TBL] [Abstract][Full Text] [Related]
19. A direct fluorometric activity assay for lipid kinases and phosphatases.
Sun J; Singaram I; Soflaee MH; Cho W
J Lipid Res; 2020 Jun; 61(6):945-952. PubMed ID: 32341006
[TBL] [Abstract][Full Text] [Related]
20. The impact of phosphatases on proliferative and survival signaling in cancer.
Narla G; Sangodkar J; Ryder CB
Cell Mol Life Sci; 2018 Aug; 75(15):2695-2718. PubMed ID: 29725697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
